Pulmonary Arterial Hypertension in Children
- Pharm. Onyehalu Jennifer

- Jan 10
- 3 min read
It was an ordinary day at the pharmacy when I received a prescription that made me pause. The medication was sildenafil, a drug more commonly used among adults in the treatment of erectile dysfunction. However, the patient was not an adult. She was five years old. The dose was smaller than the common already formulated dose, and there was no commercially available pediatric formulation. As is routine, I asked a few questions to better understand why sildenafil had been prescribed for the child. That was when I learned that the child had been diagnosed with pulmonary arterial hypertension (PAH).
To ensure she received the correct dose safely, the medication had to be compounded. While preparing it, I was reminded that some serious conditions do not announce themselves loudly. Sometimes, they arrive quietly on a small prescription for a child too young to explain what her body is going through.

Pulmonary Hypertension: The Broader Picture
Pulmonary hypertension is a condition characterized by abnormally high blood pressure in the blood vessels of the lungs. Unlike systemic hypertension, which affects the arteries throughout the body, pulmonary hypertension places increased strain on the right side of the heart, which is responsible for pumping blood into the lungs.
As pressure in the pulmonary circulation rises, the right ventricle must work harder to push blood forward. Over time, this increased workload can lead to right ventricular dysfunction and, if left untreated, right heart failure. Reduced oxygen delivery and limited physical capacity often follow.
Pulmonary hypertension is considered rare, but it can affect individuals of all ages, including infants and children.
Narrowing the Focus: Pulmonary Arterial Hypertension
Pulmonary arterial hypertension is a specific and more severe form of pulmonary hypertension. In PAH, the small arteries in the lungs become narrowed, thickened, or stiff, leading to increased resistance to blood flow. This causes a sustained rise in pulmonary arterial pressure and places significant strain on the right side of the heart.
While PAH is more commonly diagnosed in adults, it can occur in children and is often more difficult to recognize early. In pediatric patients, PAH may be idiopathic, inherited, or associated with underlying conditions.
Pulmonary Arterial Hypertension in Children
In children, PAH often develops as a complication of other medical conditions rather than occurring in isolation. These may include congenital heart defects, chronic lung disease, or genetic disorders affecting the pulmonary vessels.
Because children’s hearts and lungs are still developing, elevated pulmonary arterial pressures can interfere with normal growth and physical development. Symptoms may appear gradually, making early diagnosis challenging but critically important.

Common Causes of PAH in Children
Pulmonary arterial hypertension in children may be associated with:
Congenital heart defects that alter normal blood flow
Chronic lung disease, especially in premature infants
Genetic or idiopathic causes where no clear trigger is identified
Other conditions affecting the heart, lungs, or blood vessels
Symptoms That Are Easy to Miss
Children with PAH often present with nonspecific symptoms, which can delay diagnosis. These may include:
Shortness of breath during activity or feeding
Poor weight gain or delayed growth
Easy fatigue
Fainting episodes
Bluish discoloration of the lips or fingers
Reduced tolerance for play or exercise
Because these symptoms overlap with many common childhood illnesses, a high level of clinical suspicion is often required.
How the Diagnosis Is Made
Diagnosis usually begins with an echocardiogram, an ultrasound test that assesses heart structure and function and helps estimate pressure in the pulmonary arteries.
If pulmonary arterial hypertension is suspected, cardiac catheterization may be performed to confirm the diagnosis and measure pulmonary pressures directly. Additional tests are often used to identify the underlying cause and guide treatment decisions.

Treatment and Ongoing Care
There is currently no permanent cure for pulmonary arterial hypertension, but treatment aims to reduce symptoms, slow disease progression, and improve quality of life.
Management may include:
Oral medications such as sildenafil to relax pulmonary arteries
Other targeted therapies depending on disease severity
Oxygen therapy when needed
Careful monitoring of growth, nutrition, and physical activity
In some children, particularly those whose condition is linked to prematurity or lung immaturity, pulmonary pressures may improve as the lungs develop.
Closing Thoughts
Pulmonary arterial hypertension in children is uncommon, but its impact can be profound. It is a condition that often hides behind mild symptoms and unfamiliar prescriptions. For me, it appeared in the form of a compounded medication for a five-year-old child, quiet and unassuming, yet carrying significant weight.










Comments